drugset / Trial / NCT02201043
Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
1. Evaluate the efficacy and safety of taking thalidomide tablets once daily in the treatment of active ankylosing spondylitis. 2. To explore dose-effect relationships of taking thalidomide tablets once daily in the treatment of active ankylosing spondylitis, as well as selecting the appropriate dose for the further larger scale clinical trials.
Timeline
- Start
- 2013-02
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Thalidomide | Other / unclassified | 100 mg | Oral |
| Comparator | Thalidomide | Other / unclassified | 150 mg | Oral |